| P/E (FY) | — | Sales (TTM) | CNY 539.6M |
| Earnings (TTM) | -CNY 55.3M | ROE | −10.14% |
| Net Margin | −10.26% | ROIC | −75.17% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −1.87% |
| Market Cap | — | Trading Days | 1359 |
| 52W High | 41.72 |
| 52W Low | 5.31 |
| % Off High | −77.97% |
| YTD | −54.39% | 1Y | 33.19% |
| 3Y | −54.95% | 5Y | −95.80% |
| Since incept. (ann.) | −50.01% |
| Ann. Volatility (1Y) | 129.89% | Ann. Volatility (3Y) | 108.16% |
| Sharpe (1Y) | 0.86 | Sharpe (3Y) | 0.28 |
| Max Drawdown (1Y) | −82.85% | Max Drawdown (3Y) | −88.90% |
| Beta (3Y, vs SPY) | 2.34 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| NTRA | Natera, Inc. | $36.12B | — |
| DGX | QUEST DIAGNOSTICS INC | $26.04B | 27.0 |
| LH | LABCORP HOLDINGS INC. | $25.77B | 30.0 |
| GH | Guardant Health, Inc. | $19.04B | — |
| RDNT | RadNet, Inc. | $4.97B | — |
| VCYT | VERACYTE, INC. | $4.44B | 67.9 |
| CAI | Caris Life Sciences, Inc. | $4.41B | — |
| CELC | Celcuity Inc. | $4.02B | — |
| BLLN | BillionToOne, Inc. | $2.84B | 380.6 |
| GRAL | GRAIL, Inc. | $2.76B | — |
| FTRE | Fortrea Holdings Inc. | $1.96B | — |
| CDNA | CareDx, Inc. |
| $1.85B |
| — |
